Related references
Note: Only part of the references are listed.[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
E. J. van Helden et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Neeta Pandit-Taskar et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
John Violet et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Toward 18F-Labeled Theranostics: A Single Agent that Can Be Labeled with 18F, 64Cu, or 177Lu
Mathieu L. Lepage et al.
CHEMBIOCHEM (2020)
Luke! Luke! Don't! It's a trap!-spotlight on bias in animal experiments in nuclear oncology
Julie Nonnekens et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Quantification of PD-L1 Expression with 18F-BMS-986192 PET/CT in Patients with Advanced-Stage Non-Small Cell Lung Cancer
Marc C. Huisman et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Imaging the Distribution of Gastrin-Releasing Peptide Receptors in Cancer
Lucia Baratto et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Radiohybrid Ligands: A Novel Tracer Concept Exemplified by 18F- or 68Ga-Labeled rhPSMA Inhibitors
Alexander Wurzer et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer
Heiko Schoder et al.
CLINICAL CANCER RESEARCH (2020)
PET ligands [18F]LSN3316612 and [11C]LSN3316612 quantify O-linked-β-N-acetyl-glucosamine hydrolase in the brain
Shuiyu Lu et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET
Simone Krebs et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Advances in therapeutic peptides targeting G protein-coupled receptors
Anthony P. Davenport et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Programmed Cell Death-1/ Ligand-1 PET Imaging A Novel Tool to Optimize Immunotherapy?
Sarah R. Verhoeff et al.
PET CLINICS (2020)
Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology
Christine Rangger et al.
PHARMACEUTICALS (2020)
Chemistry for Positron Emission Tomography: Recent Advances in 11C-, 18F-, 13N-, and 15O-Labeling Reactions
Xiaoyun Deng et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
Frederik L. Giesel et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
A Metal-Free DOTA-Conjugated 18F-Labeled Radiotracer: [18F]DOTA-AMBF3-LLP2A for Imaging VLA-4 Over-Expression in Murine Melanoma with Improved Tumor Uptake and Greatly Enhanced Renal Clearance
Aron Roxin et al.
BIOCONJUGATE CHEMISTRY (2019)
89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake
Kirsten L. Moek et al.
CLINICAL CANCER RESEARCH (2019)
18F-Branched-Chain Amino Acids: Structure-Activity Relationships and PET Imaging Potential
Matthew B. Nodwell et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Immuno-PET Imaging to Assess Target Engagement: Experience from 89Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid Tumors
C. Willemien Menke-van der Houven van Oordt et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention
Anastasia Loktev et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody
Jorge A. Carrasquillo et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
A Prospective Study on 18F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
Etienne Rousseau et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals
Sai Kiran Sharma et al.
NUCLEAR MEDICINE AND BIOLOGY (2019)
Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading A Meta-analysis
Aristeidis H. Katsanos et al.
CLINICAL NUCLEAR MEDICINE (2019)
89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
Yvonne W. S. Jauw et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Evaluation of integrin αvβ6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis
Richard H. Kimura et al.
NATURE COMMUNICATIONS (2019)
18F-Labeled Cyclized α-Melanocyte-Stimulating Hormone Derivatives for Imaging Human Melanoma Xenograft with Positron Emission Tomography
Chengcheng Zhang et al.
SCIENTIFIC REPORTS (2019)
Bench to Bedside: Albumin Binders for Improved Cancer Radioligand Therapies
Joseph Lau et al.
BIOCONJUGATE CHEMISTRY (2019)
Preclinical Development and First-in-Human Imaging of the Integrin αvβ6 with [18F]αvβ6-Binding Peptide in Metastatic Carcinoma
Sven H. Hausner et al.
CLINICAL CANCER RESEARCH (2019)
Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors
Simone Krebs et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy
Rodney J. Hicks et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Targeting of activated fibroblasts for imaging and therapy
Thomas Lindner et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)
Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer 18F-4FMFES in Estrogen Receptor-Positive Breast Cancer Patients: An Ongoing Phase II Clinical Trial
Michel Paquette et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Prospective Evaluation of Ga-68-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging
Ryogo Minamimoto et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
PET Using a GRPR Antagonist Ga-68-RM26 in Healthy Volunteers and Prostate Cancer Patients
Jingjing Zhang et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
Guillaume P. Nicolas et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with Bi-213-substance P analogue
Leszek Krolicki et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Positron Emission Tomography/Computed Tomography with 89Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion
Marlene C. H. Hekman et al.
EUROPEAN UROLOGY (2018)
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein
Thomas Lindner et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies
Denise S. O'Keefe et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [Cu-64]-DOTHA(2)-PEG-RM26
Nematallah Mansour et al.
NUCLEAR MEDICINE AND BIOLOGY (2018)
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R)-4-Fluoroglutamine
Mark P. S. Dunphy et al.
RADIOLOGY (2018)
68Ga-BBN-RGD PET/CT for GRPR and Integrin αvβ3 Imaging in Patients with Breast Cancer
Jingjing Zhang et al.
THERANOSTICS (2018)
I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma
Jorge A. Carrasquillo et al.
EJNMMI RESEARCH (2018)
Site-Selective, Late-Stage C-H 18F-Fluorination on Unprotected Peptides for Positron Emission Tomography Imaging
Zheliang Yuan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Clinical translation of [18F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer
S. R. Dubash et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
Thomas Guenther et al.
PHARMACOLOGICAL REVIEWS (2018)
Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
Frederike Bensch et al.
NATURE MEDICINE (2018)
Ga-68-DOTA-GGNle-CycMSH(hex) targets the melanocortin-1 receptor for melanoma imaging
Jianquan Yang et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer
A. N. Niemeijer et al.
NATURE COMMUNICATIONS (2018)
A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors
Vivek Verma et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Performing radiosynthesis in microvolumes to maximize molar activity of tracers for positron emission tomography
Maxim Sergeev et al.
COMMUNICATIONS CHEMISTRY (2018)
Production of novel diagnostic radionuclides in small medical cyclotrons
Mateusz Adam Synowiecki et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2018)
Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agents
Marcin Czarniecki et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2018)
68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology
Simone U. Dalm et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Theranostic Perspectives in Prostate Cancer with the Gastrin Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results
Berthold A. Nock et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
First Evaluation of PET-Based Human Biodistribution and Dosimetry of 18F-FAZA, a Tracer for Imaging Tumor Hypoxia
Annarita Savi et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
18F-Fluorination of Unactivated C-H Bonds in Branched Aliphatic Amino Acids: Direct Synthesis of Oncological Positron Emission Tomography Imaging Agents
Matthew B. Nodwell et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Tactics for preclinical validation of receptor-binding radiotracers
Susan Z. Lever et al.
NUCLEAR MEDICINE AND BIOLOGY (2017)
Consensus nomenclature rules for radiopharmaceutical chemistry - Setting the record straight
Heinz H. Coenen et al.
NUCLEAR MEDICINE AND BIOLOGY (2017)
Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
Yvonne W. S. Jauw et al.
PLOS ONE (2017)
Small Prosthetic Groups in 18F-Radiochemistry: Useful Auxiliaries for the Design of 18F-PET Tracers
Ralf Schirrmacher et al.
SEMINARS IN NUCLEAR MEDICINE (2017)
Fluorine-18 labeled amino acids for tumor PET/CT imaging
Yiqiang Qi et al.
ONCOTARGET (2017)
Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET
Ido D. Weiss et al.
ONCOTARGET (2017)
Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX
Joseph Lau et al.
THERANOSTICS (2017)
[68Ga] Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F] FDG and laboratory values
Constantin Lapa et al.
THERANOSTICS (2017)
89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors
Frederike Bensch et al.
CLINICAL CANCER RESEARCH (2017)
Synthesis, Radiolabeling, and Characterization of Plasma Protein-Binding Ligands: Potential Tools for Modulation of the Pharmacokinetic Properties of (Radio)Pharmaceuticals
Cristina Mueller et al.
BIOCONJUGATE CHEMISTRY (2017)
Identification of a Novel ITGαvβ6-Binding Peptide Using Protein Separation and Phage Display
Annette Altmann et al.
CLINICAL CANCER RESEARCH (2017)
Combinatorial chemistry in drug discovery
Ruiwu Liu et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2017)
New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals
Kenneth Dahl et al.
CLINICAL AND TRANSLATIONAL IMAGING (2017)
Achievements, Challenges, and Opportunities in DNA-Encoded Library Research: An Academic Point of View
Lik Hang Yuen et al.
CHEMBIOCHEM (2017)
State of the art in anti-cancer mAbs
S. M. Chiavenna et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
From Unorthodox to Established: The Current Status of 18F-Trifluoroborate- and 18F-SiFA-Based Radiopharmaceuticals in PET Nuclear Imaging
Vadim Bernard-Gauthier et al.
BIOCONJUGATE CHEMISTRY (2016)
ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment
Laetitia E. Lamberts et al.
CLINICAL CANCER RESEARCH (2016)
Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PET/CT
Theodosia Maina et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Ga-68-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients
Jingjing Zhang et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Phase I Study of Ga-68-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
Marleen Keyaerts et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
18F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography
Sean Preshlock et al.
CHEMICAL REVIEWS (2016)
Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy
Zhibo Liu et al.
CHEMICAL SOCIETY REVIEWS (2016)
Latest Advances in OBOC Peptide Libraries. Improvements in Screening Strategies and Enlarging the Family From Linear to Cyclic Libraries
Maria C. Martinez-Ceron et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2016)
Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions
Christophe M. Deroose et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study
Yaping Luo et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT
Gary A. Ulaner et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Targeting the Neuropeptide Y1 Receptor for Cancer Imaging by Positron Emission Tomography Using Novel Truncated Peptides
Chengcheng Zhang et al.
MOLECULAR PHARMACEUTICS (2016)
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies
Erik S. Mittra et al.
PLOS ONE (2016)
Prognostic value of 18F-FET PET imaging in re-irradiation of high-grade glioma: Results of a phase I clinical trial
Soren Moller et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis
Daniel L. J. Thorek et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Novel Approaches to Thyroid Cancer Treatment and Response Assessment
Ravinder K. Grewal et al.
SEMINARS IN NUCLEAR MEDICINE (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma
Il Minn et al.
ONCOTARGET (2016)
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
Haojun Chen et al.
THERANOSTICS (2016)
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
Yvonne W. S. Jauw et al.
FRONTIERS IN PHARMACOLOGY (2016)
Physics of pure and non-pure positron emitters for PET: a review and a discussion
Maurizio Conti et al.
EJNMMI PHYSICS (2016)
Repeatability of hypoxia PET imaging using [18F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial
Catharina M. L. Zegers et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
18F-Alfatide II PET/CT in healthy human volunteers and patients with brain metastases
Chunjing Yu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET
Martha W. den Hollander et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Dosimetry and First Clinical Evaluation of the New 18F-Radiolabeled Bombesin Analogue BAY 864367 in Patients with Prostate Cancer
Bert-Ram Sah et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer
Kun Zheng et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging
Vadim Bernard-Gauthier et al.
MOLECULES (2015)
Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation
Moreno Wichert et al.
NATURE CHEMISTRY (2015)
Sodium 18F-Fluoride PET/CT of Bone, Joint, and Other Disorders
Hossein Jadvar et al.
SEMINARS IN NUCLEAR MEDICINE (2015)
Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor
Xing Yang et al.
ONCOTARGET (2015)
Prospective Study of Ga-68-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and First Application in Glioma Patients
Zhe Wang et al.
THERANOSTICS (2015)
Aptamer Selection Technology and Recent Advances
Michael Blind et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Boramino acid as a marker for amino acid transporters
Zhibo Liu et al.
SCIENCE ADVANCES (2015)
Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes
Orit Jacobson et al.
BIOCONJUGATE CHEMISTRY (2015)
Imaging tumour hypoxia with positron emission tomography
I. N. Fleming et al.
BRITISH JOURNAL OF CANCER (2015)
In Vivo Radioimaging of Bradykinin Receptor B1, a Widely Overexpressed Molecule in Human Cancer
Kuo-Shyan Lin et al.
CANCER RESEARCH (2015)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Matching chelators to radiometals for radiopharmaceuticals
Eric W. Price et al.
CHEMICAL SOCIETY REVIEWS (2014)
89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients
Sietske B. M. Gaykema et al.
CLINICAL CANCER RESEARCH (2014)
89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
Neeta Pandit-Taskar et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
[18F]Fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing αvβ3 and αvβ5 integrins
Esther Mena et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
To Serve and Protect: Enzyme Inhibitors as Radiopeptide Escorts Promote Tumor Targeting
Berthold A. Nock et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Everolimus Reduces 89Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors
Sophie J. van Asselt et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
PET Imaging of Very Late Antigen-4 in Melanoma: Comparison of 68Ga- and 64Cu-Labeled NODAGA and CB-TE1A1P-LLP2A Conjugates
Wissam Beaino et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Determination of plasma protein binding of positron emission tomography radioligands by high-performance frontal analysis
Nahid Amini et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Localized Prostate Cancer Detection with 18F FACBC PET/CT: Comparison with MR Imaging and Histopathologic Analysis
Baris Turkbey et al.
RADIOLOGY (2014)
Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men
Gesche Wieser et al.
THERANOSTICS (2014)
First use of 18F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy
Matthew J. Oborski et al.
BRAIN AND BEHAVIOR (2014)
Pilot study of 89Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancer
Idris Bahce et al.
EJNMMI RESEARCH (2014)
Development of [11C]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status
Idris Bahce et al.
CLINICAL CANCER RESEARCH (2013)
Positron Emission Tomography/Computed Tomography Identification of Clear Cell Renal Cell Carcinoma: Results From the REDECT Trial
Chaitanya R. Divgi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
First Experience of 18F-Alfatide in Lung Cancer Patients Using a New Lyophilized Kit for Rapid Radiofluorination
Weixing Wan et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Comparison of two cross-bridged macrocyclic chelators for the evaluation of 64Cu-labeled-LLP2A, a peptidomimetic ligand targeting VLA-4-positive tumors
Majiong Jiang et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
PET imaging with 89Zr: From radiochemistry to the clinic
Melissa A. Deri et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold
Koen Jansen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Clinical Relevance of 18F-FDG PET and 18F-DOPA PET in Recurrent Medullary Thyroid Carcinoma
Hans H. G. Verbeek et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Biodistribution and Radiation Dosimetry of the Integrin Marker 18F-RGD-K5 Determined from Whole-Body PET/CT in Monkeys and Humans
Mohan Doss et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
First Experience with Clinical-Grade [18F]FPP(RGD)2: An Automated Multi-step Radiosynthesis for Clinical PET Studies
Frederick T. Chin et al.
MOLECULAR IMAGING AND BIOLOGY (2012)
RADIOCHEMISTRY Flipping fluoride's reactivity
Veronique Gouverneur
NATURE CHEMISTRY (2012)
A historical perspective on the specific activity of radiopharmaceuticals: what have we learned in the 35 years of the ISRC?
Suzanne E. Lapi et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Clinical Indications of 11C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse
Maria Picchio et al.
THERANOSTICS (2012)
Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer
M. Fani et al.
THERANOSTICS (2012)
Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET
Johannes Notni et al.
EJNMMI RESEARCH (2012)
Preclinical experimental models of drug metabolism and disposition in drug discovery and development
Donglu Zhang et al.
ACTA PHARMACEUTICA SINICA B (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
20 years of DNA-encoded chemical libraries
Luca Mannocci et al.
CHEMICAL COMMUNICATIONS (2011)
Small-molecule discovery from DNA-encoded chemical libraries
Ralph E. Kleiner et al.
CHEMICAL SOCIETY REVIEWS (2011)
The potential use of 2-[18F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma
Michael Sorensen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
124I-huA33 Antibody PET of Colorectal Cancer
Jorge A. Carrasquillo et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Magnitude of Enhanced Permeability and Retention Effect in Tumors with Different Phenotypes: 89Zr-Albumin as a Model System
Carola Heneweer et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Pilot Evaluation of Anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in Recurrent Prostate Carcinoma
Bital Savir-Baruch et al.
MOLECULAR IMAGING AND BIOLOGY (2011)
Isothermal Titration Calorimetry for Measuring Macromolecule-Ligand Affinity
Michael R. Duff et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
Radiosynthesis and Evaluation of [F-18]Selectfluor bis(triflate)
Harriet Teare et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Ligand binding assays at equilibrium: validation and interpretation
Edward C. Hulme et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
The European and American Use of Exploratory Approaches for First-in-Human Studies*
Beatriz Silva-Lima et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2010)
Design and Development of Molecular Imaging Probes
Kai Chen et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Surface Plasmon Resonance: An Introduction to a Surface Spectroscopy Technique
Yijun Tang et al.
JOURNAL OF CHEMICAL EDUCATION (2010)
PET of Tumor CXCR4 Expression with 4-18F-T140
Orit Jacobson et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors
Valentina Ambrosini et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Immuno-Positron Emission Tomography in Cancer Models
Smitha Reddy et al.
SEMINARS IN NUCLEAR MEDICINE (2010)
Protein-binding assays in biological liquids using microscale thermophoresis
Christoph J. Wienken et al.
NATURE COMMUNICATIONS (2010)
Unconventional Nuclides for Radiopharmaceuticals
Jason P. Holland et al.
MOLECULAR IMAGING (2010)
PET imaging of tumor CXCR4 expression with 18F-T140
Orit Jacobson et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
In-target produced [11C]methane: Increased specific radioactivity
Jan Andersson et al.
APPLIED RADIATION AND ISOTOPES (2009)
64Cu-AMD3100-A novel imaging agent for targeting chemokine receptor CXCR4
Orit Jacobson et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research
Carolyn J. Anderson et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry-Standardization of Nomenclature
Wesley E. Bolch et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients
Pontus K. E. Boerjesson et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
PET-Based Biodistribution and Radiation Dosimetry of Epidermal Growth Factor Receptor-Selective Tracer 11C-PD153035 in Humans
Ningbo Liu et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Phage-encoded combinatorial chemical libraries based on bicyclic peptides
Christian Heinis et al.
NATURE CHEMICAL BIOLOGY (2009)
The influence of lead discovery strategies on the properties of drug candidates
Gyoergy M. Keserue et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Fluorine-18-labeled 5-fluorouracil is a useful radiotracer for differentiation of malignant tumors from inflammatory lesions
Sadatoshi Sugae et al.
ANNALS OF NUCLEAR MEDICINE (2008)
High throughput screening for orphan and liganded GPCRs
Shou-Hua Xiao et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2008)
Alternative Splicing and Tumor Progression
Claudia Ghigna et al.
CURRENT GENOMICS (2008)
Anesthesia and other considerations for in vivo imaging of small animals
Isabel J. Hildebrandt et al.
ILAR JOURNAL (2008)
Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer
Walter Jentzen et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix
Jason S. Lewis et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Peptide-Based Probes for Cancer Imaging
Jean Claude Reubi et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
18F-EF5: A New PET Tracer for Imaging Hypoxia in Head and Neck Cancer
Gaber Komar et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Partial-volume effect in PET tumor imaging
Marine Soret et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Clinical applications of PET in brain tumors
Wei Chen
JOURNAL OF NUCLEAR MEDICINE (2007)
Synthesis and reactivity of [F-18]-N-fluorobenzenesulfonimide
Harriet Teare et al.
CHEMICAL COMMUNICATIONS (2007)
From combinatorial chemistry to cancer-targeting peptides
Olulanu H. Aina et al.
MOLECULAR PHARMACEUTICS (2007)
High-throughput sequence determination of cyclic peptide library members by partial Edman degradation/mass spectrometry
Sang Hoon Joo et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Streamlining lead discovery by aligning in silico and high-throughput screening
John W. Davies et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2006)
Combinatorial chemistry identifies high-affinity peptidomimetics against α4β1 integrin for in vivo tumor imaging
Li Peng et al.
NATURE CHEMICAL BIOLOGY (2006)
A highly flexible tRNA acylation method for non-natural potypeptide synthesis
H Murakami et al.
NATURE METHODS (2006)
Positron tomographic assessment of androgen receptors in prostatic carcinoma
F Dehdashti et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Phage display-derived peptides as a therapeutic alternatives to antibodies
RC Ladner et al.
DRUG DISCOVERY TODAY (2004)
Quantification in PET
PD Acton et al.
RADIOLOGIC CLINICS OF NORTH AMERICA (2004)
High-affinity binders selected from designed ankyrin repeat protein libraries
HK Binz et al.
NATURE BIOTECHNOLOGY (2004)
Peptide receptors as molecular targets for cancer diagnosis and therapy
JC Reubi
ENDOCRINE REVIEWS (2003)
A novel and rapid encoding method based on mass spectrometry for one-bead-one-compound small molecule combinatorial libraries
AM Song et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Lead discovery using molecular docking
BK Shoichet et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2002)
Lead compounds discovered from libraries
A Golebiowski et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2001)
Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase)
AP Kozikowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Share Paper
